DIEUSAERT PHARMA
The computed 12-month bankruptcy probability of DIEUSAERT PHARMA is 0.8% (low). The company has been active since 2013 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 12 yrs |
| Locations | 1 |
| Publications | 1 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 30-06-2025 | verkort | 17-12-2025 | 2025-00583279 |
| 30-06-2024 | verkort | 02-01-2025 | 2025-00628644 |
| 30-06-2023 | verkort | 22-12-2023 | 2023-00534748 |
| 30-06-2022 | verkort | 31-01-2023 | 2023-00013773 |
| 30-06-2021 | micro | 31-01-2022 | 2022-02800227 |
| 30-06-2020 | micro | 29-01-2021 | 2021-02400481 |
| 30-06-2019 | micro | 16-12-2019 | 2019-75900486 |
| 30-06-2018 | micro | 11-01-2019 | 2019-00800533 |
| 30-06-2017 | micro | 21-12-2017 | 2017-72400236 |
| 30-06-2016 | verkort | 21-12-2016 | 2016-70600591 |
| NACE primary | Retail trade(47730) |
| Legal form | Private limited company(610) |
| Incorporation | 03-10-2013 |
| Status | Active |
| Postal code | 8953 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 33032B1121/00T003 | Flanders | 913 m² | 1 · 343 m² | 8.3 m · 1 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
14-02-2024 Articles of association amended, alignment with the new Companies Code, legal-form conversion and change of corporate purpose
Technical details
{
"notary": {
"name": "Arne De Geeter",
"firm_city": null,
"firm_name": "West Notarissen",
"office_city": "Kortrijk",
"is_associated": true
},
"act_meta": {
"language": "nl",
"pub_date": "2024-02-14",
"filing_date": "2024-02-12",
"act_kind_objet": "DOEL, WIJZIGING RECHTSVORM, ALGEMENE VERGADERING"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2023-12-12",
"unanimous": true
},
"statute_change": {
"kinds": [
"wvv_adaptation",
"legal_form_change",
"object_change",
"full_restatement"
],
"scope": "full_restatement",
"trigger": "wvv_adaptation",
"language_after": "nl",
"language_before": "nl"
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0539.940.996",
"name_full_after": "DIEUSAERT PHARMA",
"legal_form_after": "Besloten vennootschap met beperkte aansprakelijkheid",
"name_full_before": "DIEUSAERT PHARMA",
"current_zetel_raw": "Ieperstraat(Wijtsch) 115 8953 Heuvelland",
"legal_form_before": "Besloten vennootschap met beperkte aansprakelijkheid"
},
"special_mandates": [
{
"holder_kbo": null,
"holder_name": "ACCOFISC",
"scope_categories": [
"kbo",
"ubo",
"btw"
],
"with_substitution": true
},
{
"holder_kbo": null,
"holder_name": "LUMINAD",
"scope_categories": [
"kbo",
"ubo",
"btw"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "Artikel 3 van de statuten wordt integraal vervangen door de nieuwe tekst van de statuten.",
"new_text": null,
"change_kind": "replaced",
"article_title": null,
"article_number": "3"
}
],
"governance_change": null,
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Arne DE GEETER",
"org_rep_person_name": null
},
"co_filed_documents": [
"afschrift van de akte",
"geco\u00F6rdineerde statuten"
],
"shareholder_rights": null,
"voorwerp_change_summary": "De algemene vergadering beslist het voorwerp van de vennootschap te wijzigen en bijgevolg artikel 3 van de statuten integraal te vervangen.",
"capital_structure_change": {
"operations": [
"wvv_capital_release"
],
"split_ratio": null,
"shares_after": 300,
"shares_before": 300,
"capital_after_eur": null,
"capital_before_eur": null,
"share_classes_after": [
{
"count": null,
"label": "aandelen met of zonder stemrecht",
"rights_summary": "Recht op winst en vereffeningssaldo",
"voting_per_share": 1.0
},
{
"count": null,
"label": "aandelen met meervoudig stemrecht",
"rights_summary": "Meervoudig stemrecht",
"voting_per_share": null
},
{
"count": null,
"label": "aandelen die een groter of kleiner recht geven op de winst en/of het liquidatiesaldo",
"rights_summary": "Specifiek recht op winst en/of liquidatiesaldo",
"voting_per_share": null
},
{
"count": null,
"label": "aandelen die enkel recht geven op toekomstige winsten en/of op gereserveerde winsten",
"rights_summary": "Recht op toekomstige winsten en/of gereserveerde winsten",
"voting_per_share": null
},
{
"count": null,
"label": "aandelen met specifieke rechten die afwijken van de rechten van de reeds bestaande aandelen",
"rights_summary": "Specifieke rechten die afwijken van de bestaande rechten",
"voting_per_share": null
}
]
},
"coordinated_text_lineage": null
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | DIEUSAERT PHARMA |